Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis

Publisher： Karger

E-ISSN： 1423-0232|81|3-4|175-183

ISSN： 0030-2414

Source： Oncology, Vol.81, Iss.3-4, 2011-11, pp. : 175-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

By  

Oncology, Vol. 87, Iss. 3, 2014-07 ,pp. : 167-172

Karger

Access to resources Recommend Favorite

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy

By  

Oncology, Vol. 82, Iss. 5, 2012-04 ,pp. : 261-268

Karger

Access to resources Recommend Favorite

Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 167-174

Karger

Access to resources Recommend Favorite

Bevacizumab plus Oxaliplatin-Based Regimens for the Treatment of Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 431-439

Karger

Access to resources Recommend Favorite

A New Formula for Predicting Liver Metastasis in Patients with Colorectal Cancer: Immunohistochemical Analysis of a Large Series of 439 Surgically Resected Cases

By  

Oncology, Vol. 75, Iss. 1-2, 2008-08 ,pp. : 32-41

Karger

Access to resources Recommend Favorite